References
- Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133–42
- Calleja-Agius J, Brincat MP. The urogenital system and the menopause. Climacteric 2015;18:18–22
- Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 2015;18:219–25
- DiBonaventura M, Luo X, Moffatt M, et al. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. J Womens Health (Larchmt) 2015;24:713–22
- Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 2016;215:704–11
- Sturdee DW, Panay N, International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
- Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas 1995;22:S1–S5
- Makita K, Ohta H, Komukai S, et al. State of health-maintenance outpatient care among middle-aged and elderly patients 5 months after opening our classroom. J Japan Menopause Soc 1993;1:86–92
- Japanese Ministry of Health, Labor and Welfare. National Basic Survey on Living Conditions 2016. Available from: www.mhlw.go.jp/toukei/list/20-21.html (in Japanese) [last accessed 13 May 2020]
- Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090–6
- Cardozo L, Bachmann G, McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722–7
- Genazzani AR, Schneider HP, Panay N, et al. The European Menopause Survey 2005: women’s perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 2006;22:369–75
- Takamatsu K, Ohta H, Kasuga M, et al. Vaginal symptoms in Japanese postmenopausal women: comparison with other climacteric symptoms. Climacteric 2001;4:299–305
- Takamatsu K, Ito K, Ogawa M, et al. Vaginal symptoms among postmenopausal Japanese women—an analysis of an online survey. J Jpn Soc Menopause Women’s Health 2013;21:36–41 (in Japanese)
- Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010;67:233–8
- Pastore LM, Carter RA, Hulka BS, et al. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas 2004;49:292–303
- Salonia A, Zanni G, Nappi RE, et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 2004;45:642–6488; discussion 648
- Hansen BL. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol 2004;46:229–34
- Møller LA, Lose G. Sexual activity and lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:18–21
- Oh SJ, Ku JH, Choo MS, et al. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol 2008;15:62–7; discussion 67
- Sako T, Inoue M, Watanabe T, et al. Impact of overactive bladder and lower urinary tract symptoms on sexual health in Japanese women. Int Urogynecol J 2011;22:165–9